HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury.

AbstractOBJECTIVE:
Apoptosis is the early and predominant form of cell death in infarcted myocardia. The aim of the study was to investigate the effects of trimetazidine (TMZ) and N-acetylcysteine (NAC), used alone or in combination, on oxidative stress, infarct size, and ischemia-reperfusion (IR)-induced cardiomyocyte apoptosis in a rat model of myocardial IR.
METHODS AND RESULTS:
Myocardial IR was established by ligating an area under the left main coronary artery for 30 min followed by 3 h of reperfusion. Saline (1 ml/kg), NAC (50, 150 mg/kg), or TMZ (3, 5 mg/kg) was intravenously injected during the middle of the ischemic period. At the end of the reperfusion, blood samples were collected from the animals to measure serum M30 and M65 levels, which are markers of cell death, the S100b level, which is a marker of inflammation, and the malondialdehyde (MDA) level, which is a marker of oxidative stress. The infarct size was evaluated as the ratio of the infarct area to the risk area. Apoptotic activation was assessed by caspase-3 immunostaining and a TUNEL assay. TMZ and NAC, either alone or in combination, significantly reduced serum MDA levels, infarct area and apoptotic activity compared to those observed in saline group. Interestingly, the infarct area was more smaller in TMZ (3 and 5 mg/kg) injected groups (9.72 ± 1.3% and 9.96 ± 2.3%) than those observed in NAC (50 and 150 mg/kg) (16.1 ± 2.5% and 19.1 ± 2.14%) or TMZ (5 mg/kg)- NAC (150 mg/kg) combination groups (16.9 ± 1.6%). However, the apoptotic activity was reduced more significantly in the combination of TMZ (5 mg/kg)-NAC (50 mg/kg) compared to TMZ-only group. Neither TMZ or NAC treatments nor the combination of the drugs significantly affected serum M30, M65 and S100B levels.
CONCLUSION:
Intravenous NAC and TMZ administration decreased oxidative stress, infarct area and apoptotic activity in a rat model of IR. Although the combination treatment was more effective in reducing the apoptotic activity than either treatment groups alone, TMZ treatment was more successful in reducing the infarct area than NAC or combination treatments. Present results suggest that, in addition to mechanical attempts to secure myocardial reperfusion, the use of TMZ and NAC may help to reduce IR injury.
AuthorsTunay Şentürk, Sinan Çavun, Berrin Avcı, Aysun Yermezler, Zehra Serdar, Vahide Savcı
JournalAtherosclerosis (Atherosclerosis) Vol. 237 Issue 2 Pg. 760-6 (Dec 2014) ISSN: 1879-1484 [Electronic] Ireland
PMID25463117 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Fatty Acids
  • S100 Calcium Binding Protein beta Subunit
  • S100b protein, rat
  • Malondialdehyde
  • Casp3 protein, rat
  • Caspase 3
  • Glutathione
  • Glucose
  • Trimetazidine
  • Oxygen
  • Acetylcysteine
Topics
  • Acetylcysteine (administration & dosage)
  • Animals
  • Apoptosis (drug effects)
  • Blood Pressure
  • Caspase 3 (metabolism)
  • Cell Death
  • Coronary Vessels (pathology)
  • Disease Models, Animal
  • Fatty Acids (chemistry)
  • Glucose (chemistry)
  • Glutathione (chemistry)
  • Inflammation
  • Male
  • Malondialdehyde (chemistry)
  • Myocardial Ischemia (drug therapy)
  • Myocardium (pathology)
  • Myocytes, Cardiac (cytology)
  • Oxidative Stress
  • Oxygen (chemistry)
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (drug therapy)
  • S100 Calcium Binding Protein beta Subunit (blood)
  • Trimetazidine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: